LETTER TO THE EDITOR
TITLE: Sarcoid-like reaction in a child following prolonged
therapeutic exposure to dabrafenib and trametinib for BRAF V600E mutated
hypothalamic/ chiasmatic glioma
Authors : Mari Wilhelmsson MD, PhD1,2; Foo Jen
Chun MD1; Rae S M Yeung MD, PhD3;
Fiona Krtizinger MBChB, MMed4; Tata McKeown,
MSc1; Ailish Coblentz, MD5; Birgit
Ertl-Wagner, MD5; Uri Tabori MD,
PhD1, Ute Bartels MD, PhD 1; Anirban
Das MBBS, MD, DM 1
AFFILIATIONS:
1. Division of Haematology Oncology, The Hospital for Sick Children,
Toronto, Ontario, Canada; 2. Department of Women´s and Children´s
Health, Karolinska Institutet, Stockholm, Sweden. 3. Division of
Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
4. Division of Respiratory Medicine, The Hospital for Sick Children,
Toronto, Ontario, Canada. 5. Department of Diagnostic Imaging, The
Hospital for Sick Children, Toronto, Ontario, Canada.
WORD COUNT: 853
FIGURES: 1
RUNNING TITLE: Sarcoid-like reaction with BRAF/MEK-inhibition
KEYWORDS : MEK-inhibitor, BRAF inhibitor,
sarcoidosis/sarcoid‑like reaction (S/SLR), Low-grade glioma, pediatric